Holen Sie sich die Stockscreener-App
1.82
1.62%
-0.03
Vorhandelsmarkt:
1.82
Schlusskurs vom Vortag:
$1.85
Offen:
$1.84
24-Stunden-Volumen:
7.27M
Relative Volume:
1.26
Marktkapitalisierung:
$954.89M
Einnahmen:
$1.92B
Nettoeinkommen (Verlust:
$-85.55M
KGV:
-10.94
EPS:
-0.1663
Netto-Cashflow:
$-68.98M
1W Leistung:
-5.70%
1M Leistung:
-9.45%
6M Leistung:
-43.48%
1J Leistung:
-52.23%
1-Tages-Spanne:
$1.78
$1.865
1-Wochen-Bereich:
$1.78
$1.99
52-Wochen-Spanne:
$1.78
$3.92
Clover Health Investments Corp Stock (CLOV) Company Profile
Firmenname
Clover Health Investments Corp
Sektor
Branche
Telefon
(201) 432-2133
Adresse
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
1.82 | 954.89M | 1.92B | -85.55M | -68.98M | -0.1663 |
UNH
Unitedhealth Group Inc
|
272.28 | 247.14B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
72.80 | 92.62B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
265.87 | 70.10B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
290.33 | 64.08B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
172.23 | 20.68B | 129.66B | 1.20B | 375.00M | 9.8083 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-02 | Hochstufung | Cowen | Underperform → Market Perform |
| 2022-01-19 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Underperform |
| 2021-09-02 | Fortgesetzt | Citigroup | Neutral |
| 2021-07-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-02-02 | Eingeleitet | Citigroup | Buy |
| 2021-02-01 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
Tranche Update on Clover Health Investments, Corp.'s Equity Buyback Plan announced on May 7, 2024. - marketscreener.com
Clover Health Investments (NASDAQ:CLOV) Hits New 52-Week Low After Analyst Downgrade - MarketBeat
Earnings Recap: Will Clover Health Investments Corp benefit from geopolitical trends2026 Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Published on: 2026-03-22 02:36:37 - baoquankhu1.vn
Canaccord Lowers Clover Health (CLOV) Price Target to $3.20, Mai - GuruFocus
Canaccord Genuity Group Has Lowered Expectations for Clover Health Investments (NASDAQ:CLOV) Stock Price - MarketBeat
Clover Health (CLOV) Subsidiary Enhances Flu Vaccination and Red - GuruFocus
Counterpart Assistant Linked to Fewer Flu-Related Acute Care Events for COPD and CHF Patients - National Today
When doctors used this AI prompt, high-risk patients had fewer flu ER trips - Stock Titan
Insider Sell: Jamie Reynoso Sells Shares of Clover Health Investments Corp (CLOV) - GuruFocus
Clover Health: Strong Growth, Improving Margins, And A Mispriced Stock (NASDAQ:CLOV) - Seeking Alpha
Clover Health Investments Stock (ISIN: US18914F1030) Faces Medicare Headwinds Amid Clover Health Tur - AD HOC NEWS
Clover Health CEO Reynoso sells $11,141 in shares By Investing.com - Investing.com Australia
Clover Health CEO Reynoso sells $11,141 in shares - Investing.com
Clover Health (CLOV) Medicare Advantage CEO sells 5,833 shares in planned trade - Stock Titan
CLOV (NASDAQ: CLOV) Form 144 shows 5,833 RSUs proposed sale; prior 10b5-1 sales listed - Stock Titan
Clover Health Investments (CLOV) price target decreased by 11.47% to 2.92 - MSN
Clover Health stock hits 52-week low at $1.92 By Investing.com - Investing.com South Africa
Sentiment Review: What is the Moat Score of Clover Health Investments CorpWeekly Stock Analysis & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
Clover Health (CLOV) exec Reynoso has shares withheld to cover RSU tax obligations - Stock Titan
RSU vesting triggers tax share withholding at Clover Health (CLOV) - Stock Titan
Clover Health (CLOV) CEO has shares withheld to cover RSU taxes - Stock Titan
Clover Health stock hits 52-week low at $1.92 - Investing.com
Clover Health Investments (NASDAQ:CLOV) Reaches New 12-Month LowShould You Sell? - MarketBeat
Gains Report: How does Clover Health Investments Corp perform in inflationary periods2026 Sentiment & Technical Buy Zone Confirmation - baoquankhu1.vn
2,768,088 Shares in Clover Health Investments, Corp. $CLOV Purchased by Divisadero Street Capital Management LP - MarketBeat
Clover Health Investments Touts AI Medicare Advantage Model, Targets GAAP Profitability in 2026 at Leerink Conference - Yahoo Finance
Clover Health (CLOV) Announced a New Pharmacy Pilot Program in New Jersey - MSN
CLOV Stock Price, Quote & Chart | CLOVER HEALTH INVESTMENTS CO (NASDAQ:CLOV) - ChartMill
Key facts: Clover Health targets GAAP profitability by 2026; partners with Kno2 - TradingView
Clover Health at Leerink Conference: AI-Driven Growth and Profitability - Investing.com
Clover Health Investments Corp And Kno2 Enable Real-Time Patient Access To Claims Data - marketscreener.com
UPDATEDMoving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives - Bitget
Clover Health Partners with Kno2 to Enhance Interoperability in Healthcare Data Exchange - Quiver Quantitative
UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives - marketscreener.com
Clover Health sees 2026 revenue above consensus - MSN
Clover Health Investments (NASDAQ:CLOV) Hits New 52-Week LowHere's What Happened - MarketBeat
A Look At Clover Health (CLOV) Valuation After TEFCA Interoperability Milestone Gains Attention - simplywall.st
Vanguard Group Inc. Sells 1,186,026 Shares of Clover Health Investments, Corp. $CLOV - MarketBeat
Guidance Update: Is Clover Health Investments Corp a potential multi baggerMarket Movers & Real-Time Stock Entry Alerts - baoquankhu1.vn
Clover Health publishes supplemental Q&A for fourth quarter 2025 earnings - Investing.com Nigeria
Clover Health Highlights Transparency With Supplemental Earnings Q&A - TipRanks
Clover Health publishes supplemental Q&A for fourth quarter 2025 earnings By Investing.com - Investing.com Canada
Clover Health (Nasdaq: CLOV) Fourth Quarter 2025 Supplemental Q&A - marketscreener.com
Clover publishes supplemental Q4 2025 FAQ responses to boost investor engagement - TradingView
Insider Sell: Brady Priest Sells 175,000 Shares of Clover Health Investments Corp (CLOV) - GuruFocus
Clover Health Tests Interoperability Leadership Against Volatile Share Performance - simplywall.st
Insider Selling: Clover Health Investments (NASDAQ:CLOV) CEO Sells 175,000 Shares of Stock - MarketBeat
Clover Health (CLOV) Valuation Check After TEFCA Milestone And Profitability Guidance - Yahoo Finance
Clover Health Investments (NASDAQ:CLOV) Given New $2.50 Price Target at Leerink Partners - MarketBeat
Leerink Partners Lowers Price Target for Clover Health (CLOV) | - GuruFocus
Finanzdaten der Clover Health Investments Corp-Aktie (CLOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.22%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):